In Brief This Week: Response Genetics, Dow AgroSciences, Monsanto, Stokes Bio, Cellectis, Sage Bionetworks, HairDx | GenomeWeb

NEW YORK (GenomeWeb News) – Response Genetics said this week that it is expanding its sales force for its ResponseDx genetic test panels by 50 percent.

Los Angeles-based Response Genetics said that it would increase its internal sales force from 10 to 15 to sell ResponseDx, a PCR-based test used to analyze the expression of genes that correlate to commonly used chemotherapy agents.

The company said that it plans to add the sales representatives to its sales force by the end of the first quarter this year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.